Antibody generation
We provide flexible and professional antibody generation of both polyclonal and monoclonal antibodies through our trusted partners, together with a large range of associated services including optimisation and production of antibody from existing hybridomas, adaptation of cells to serum-free conditions, bulk antibody production and purification. We also provide custom synthesis services for the generation of the peptide antigens.
Antibody generation services
Here at Altabioscience, we have a wide range of options for the production of both monoclonal antibodies and polyclonal antibodies. Contact us to learn more or if you have any questions.
Antibody generation process
Process of monoclonal antibody generation
Our monoclonal antibody generation process is identified by five phases. A typical monoclonal antibody project may yield up to 10 positive wells at the fusion screening stage and, after cloning, can deliver two or three stable monoclonal antibodies. However, the number of monoclonal antibodies generated in a project cannot be guaranteed. The project is charged per line of limiting dilution cloning to allow for ultimate flexibility and for greater numbers of candidates to be brought forward past the first stage. This gives a greater degree of flexibility in comparison to being priced by a set number of hybridomas. Read more about custom monoclonal antibodies.
Process of polyclonal antibody generation
The standard inoculation procedure for a polyclonal antibody in a rabbit involves six immunisations at two-week intervals and three bleeds (with an additional pre-immune bleed). If required, this program can be modified and/or extended to fit specific requirements, provided it complies with the licence held by the animal facility. The standard program uses Freund’s Adjuvant but other adjuvants are available on request. Test bleeds are available for client assays after each bleed if required. The terminal serum is delivered at the end of the program, either raw or purified. Read more about custom polyclonal antibodies.
Latest news
AltaBioscience Attending ELRIG Drug Discovery 2025 in Liverpool
Our Managing Director will be attending ELRIG Drug Discovery 2025 in Liverpool on 21–22 October. As a trusted partner in peptide synthesis, protein sequencing, and amino acid analysis, AltaBioscience is committed to supporting innovation and collaboration across the scientific community.
AltaBioscience Heads to Amsterdam for The Future of Protein Production 2025
We will be exhibiting at the Future of Protein Production 2025 in Amsterdam on Oct 29–30. Visit Booth #20 to explore our protein analysis and custom synthesis solutions. Read more to download your FREE exhibition pass.
Join Us at the Inaugural NAPIC Conference
Come meet us at the Inaugural NAPIC Conference on September 15th-16th 2025 at The Diamond, University of Sheffield.